MREO vs PYPL · $48.7M cap vs P/E 7.9, rev $33.17B
Mereo BioPharma Group PLC ADR (MREO) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
MREO currently screens at market cap $48.7M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the MREO and PYPL stock pages for the full models.
Not investment advice.